Articles

Treatment of Methamphetamine Dependence with Electroconvulsive Therapy (ECT) in Iran: A Critical Note

Abstract

Objevtive: This comment article reviews the literature to explore whether the use of ECT for the treatment of methamphetamine dependence can be justified by scientific rationale and/or evidence.
Method: This article reviews the literature on the use of ECT in addictive disorders. It describes a patient with methamphetamine dependence treated with ECT. It then offers a historical review of the moral and ethical difficulties encountered in the treatment of addictive disorders. It proposes a dynamic understanding as to why clinicians might deploy such brutal actions in the face of hopeless and emotionally intense encounters.
Results: We found no scientific evidence or justification for ECT as a treatment of methamphetamine dependence or as the first line treatment for methamphetamine-induced psychiatric comorbidities
Conclusion:
the current available evidence does not support using ECT for the treatment of addictive disorders, and hence is unethical, unacceptable and inhumane and warrants immediate social and po itical attention.

Shariatirad S, Maarefvand M, Ekhtiari H. Emergence of a methamphetamine crisis in Iran. Drug Alcohol Rev 2013; 32: 223-224.

Shariatirad S, Maarefvand M, Ekhtiari H. Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran. Int J Drug Policy 2013; 24: e115-116.

Angoorani H, Narenjiha H, Tayyebi B, Ghassabian A, Ahmadi G , Assari S. Amphetamine use and its associated factors in body builders: a study from Tehran, Iran. Arch Med Sci 2012; 8: 362-367.

Zarghami M. Methamphetamine has changed the profile of patients utilizing psychiatric emergency services in Iran. Iranian Journal of Psychiatry and Behavioral Sciences 2011; 1-5.

Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH, et al. Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev 2007; 17: 275-297.

Marshall BD, Werb D. Health outcomes associated with methamphetamine use among young people: a systematic review. Addiction 2010; 105: 991-1002.

Rawson RA, Gonzales R, Pearce V, Ang A, Marinelli-Casey P, Brummer J, et al. Methamphetamine dependence and human immunodeficiency virus risk behavior. J Subst Abuse Treat 2008; 35: 279-284.

Shoptaw S, Peck J, Reback CJ, Rotheram-Fuller E. Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment. J Psychoactive Drugs 2003; 35: 161-168.

McKetin R, Ross J, Kelly E, Baker A, Lee N, Lubman DI, et al. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. Drug Alcohol Rev 2008; 27: 277-285.

Zweben JE, Cohen JB, Christian D, Galloway GP, Salinardi M, Parent D, et al. Psychiatric symptoms in methamphetamine users. Am J Addict 2004; 13: 181-190.

Vocci FJ, Montoya ID. Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence. Curr Opin Psychiatry 2009; 22: 263-268.

Menza TW, Jameson DR, Hughes JP, Colfax GN, Shoptaw S, Golden MR. Contingency management to reduce methamphetamine use and sexual risk among men who have sex with men: a randomized controlled trial. BMC Public Health 2010; 10: 774.

Karila L, Weinstein A, Aubin HJ, Benyamina A, Reynaud M, Batki SL. Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clin Pharmacol 2010; 69: 578-592.

Schifano F, Corkery JM , Cuffolo G. Smokable ("ice", "crystal meth") and non smokable amphetamine-type stimulants: clinical pharmacological and epidemiological issues, with special reference to the UK. Ann Ist Super Sanita 2007; 43: 110-115.

Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 1988; 85: 5274-5278.

White WL. Slaying the dragon: the history of addiction treatment and recovery in America: Chestnut Health Systems/Lighthouse Institute; 1998.

Barrows S, Room R. Drinking: Behavior and Belief in Modern History: University of California Press; 1991.

Rafter NH. White trash: the eugenic family studies, 1877-1919: Northeastern University Press; 1988.

Roper P. Drug addiction, psychotic illness and brain self-stimulation: effective treatment and explanatory hypothesis. Can Med Assoc J 1966; 95: 1080-1086.

Grelotti DJ, Kanayama G , Pope HG, Jr. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature. Am J Psychiatry 2010; 167: 17-23.

Valenstein ES. The Psychosurgery Debate: Scientific, Legal, and Ethical Perspectives: W. H. Freeman; 1980.

Files
IssueVol 9 No 3 (2014) QRcode
SectionArticles
Keywords
#No Keywords#

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Roshanaei-Moghaddam B, Pauly MC. Treatment of Methamphetamine Dependence with Electroconvulsive Therapy (ECT) in Iran: A Critical Note. Iran J Psychiatry. 1;9(3):184-7.